Our TriGL-P (Reta) series is a multi-receptor GLP-3 agonist, designed for researchers mapping complex metabolic signalling. As a single peptide engaging GLP‑1, GIP, and glucagon receptor pathways, it allows precise interrogation of incretin-related networks, dose - response behaviour, and receptor crosstalk in vitro.

We supply AL-M-Reta in a research-grade format suitable for endocrine modelling, pharmacodynamic profiling, and comparative studies alongside other incretin-mimetic peptides. Consistent batch specifications and verifiable testing (COA available on request) support reproducible experimental design for data-driven teams.

For projects requiring higher total peptide content, we also carry larger AL-M-Reta vial strengths within the same classification framework, allowing scaling without changing compound identity.

Each vial purchased is supplied with complimentary 3ml Ascend Labs Bacteriostatic Water

Disclaimer: Research use only. Not for human or animal use or consumption.